Igniting Your UDS+ Journey
Your Partner in supporting Community Health Centers across the nation!
A major function of Uniform Data System modernization, also known as UDS+, is to improve UDS tracking and drill down quality care reporting. In other words, to promote the ability to report on data at the patient level rather than through large, aggregate lumps of patient population data.
NextGen Healthcare is excited to announce that we have officially passed HRSA’s synthetic data testing requirements for UDS+ Cohort 1.
This significant milestone marks NextGen as one of the first EHR vendors to achieve this distinction. As a result, we are now officially listed as a qualified vendor on the BPHC contact form to support our first round of beta clients testing in Cohort 1. We are truly excited about this achievement and are eager to continue our journey with our valued clients, and our partners at HRSA.
What do the different UDS+ Cohorts mean to you?
UDS+ Cohort Descriptions and Benefits
Cohort 1 - March Submission and Full Data Review
Description: Submit live data during the voluntary UDS+ submission period before March 31st.
Submission: February through March 2024
Benefits:
Dedicated submission report.
Detailed submission review.
Full Data Review - Detailed review and analysis with UDS and UDS+ comparison reports.
Heavily influence future data and reporting needs.
Heavily influence future IG changes.
Cohort 2 - Extended Testing, June Submission, Partial Data Review
Description: Continue Synthetic Testing and submit live data during the voluntary UDS+ submission period before June 30th.
Submission: May through June 2024
Benefits:
Allow continued synthetic testing through Spring 2024.
Allow voluntary 2023 data submissions through mid-2024.
Allow testing and submission for unique scenarios (multi-system for example).
Partial data review and analysis.
Influence future UDS+ needs.
Cohort 3 - Focus on Testing
Description: Vendors and Health Centers interested in participating but have not participated in testing and still monitoring UDS+ participation and readiness.
No Voluntary 2023 Submission
Benefits:
Continued engagement in public forums and outreach efforts to navigate any looming questions or plans for UDS+
Continued support and encouragement to participate in Synthetic Testing in 2023
Note: Vendors (submitting on behalf of a Health Center) and Health Centers using in-house systems must successfully complete testing before submitting UDS+ data.
Check out our UDS+ education miniseries
UDS Modernization: 101
Learn what you need to know about the current UDS+ criteria, how you can prepare for it, and how NextGen Healthcare provides solutions to help navigate UDS+ submissions.
Patient-Level Data Reporting
As UDS modernization unfolds, your organization can’t afford to not dive deep into patient-level data and how to optimize your care strategy. The good news? NextGen Healthcare has you covered.
Health Quality Measures Dashboard: An Overview
Get introduced to NextGen® HQM—an efficient health quality measure module that gathers the data needed to report quality measures to multiple CMS programs and qualify for financial incentives.
Putting It All Together to Achieve Success
UDS+ makes integrated whole-person care something to strive for. Ensure you have the resources to integrate and refresh your systems so that you can improve the overall experience of care for your staff, providers, and patients.
©2023 NXGN Management, LLC. All Rights Reserved. | Accessibility | Certifications & Cost Disclosures | EHRA developer code of conduct | Privacy Policy | Legal notices
NextGen Healthcare supports rigorous industry and regulatory standards so that our clients can successfully participate in various quality reporting and incentive programs.
